Sandoz being top generic drug maker by merger of Hexal.

Published: 2005-06-27 06:56:00

Updated: 2005-06-27 06:56:00

Hexal Korea, the first import company of generic drugs in Korea, launched its business in January this year but will be soon renamed to Sandoz Korea probably around the 2nd half of this year since Novartis took over Hexal, a Germany generic drug company, in February and officially took an approva...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK